-
1دورية أكاديمية
المؤلفون: Stratigos, Alexander J., Garbe, Claus, Dessinioti, Clio, Lebbe, Célèste, van Akkooi, Alexander J.C., Bataille, Véronique A., Bastholt, Lars, Dreno, Brigitte, Dummer, Reinhard G., Fargnoli, Maria Concetta, Forsea, Ana Maria, Harwood, Catherine Anne, Hauschild, Axel, Hoeller, Christoph, Kandolf-Sekulovic, Lidija O., Kaufmann, Roland, Kelleners-Smeets, Nicole W.J., Lallas, Aimilios, Leiter, Ulrike, Malvehy, Josep, del Marmol, Véronique, Moreno-Ramirez, David, Pellacani, Giovanni, Peris, Ketty, Saiag, Phillippe, Tagliaferri, Luca, Trakatelli, Myrto Georgia, Ioannides, Demetrios, Vieira, Ricardo José David Costa, Zalaudek, Iris, Arenberger, Petr, Eggermont, Alexander M.M., Röcken, Martin, Grob, Jean Jacques, Lorigan, Paul C.
المساهمون: Sénopole Hopital Saint Louis, Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunology and New Concepts in ImmunoTherapy (INCIT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Assistance Publique - Hôpitaux de Marseille (APHM), The development of the current set of guidelines wassupported solely by funds of the EADO which were usedto mainly support the consensus meeting without honoraria and without reimbursement of travel costs.
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-04229549Test ; European Journal of Cancer, 2023, 193, ⟨10.1016/j.ejca.2023.113251⟩.
مصطلحات موضوعية: Advanced, Diagnosis, High-risk, Immunosuppression, Invasive cutaneous squamous cell carcinoma, Locally advanced cSCC, Metastatic cSCC, Prevention, Prognosis, Staging, [SDV.CAN]Life Sciences [q-bio]/Cancer
العلاقة: hal-04229549; https://hal.science/hal-04229549Test
-
2دورية أكاديمية
المؤلفون: Stratigos, Alexander J., Garbe, Claus, Dessinioti, Clio, Lebbe, Célèste, van Akkooi, Alexander J.C., Bataille, Véronique A., Bastholt, Lars, Dreno, Brigitte, Dummer, Reinhard G., Fargnoli, Maria Concetta, Forsea, Ana Maria, Harwood, Catherine Anne, Hauschild, Axel, Hoeller, Christoph, Kandolf-Sekulovic, Lidija O., Kaufmann, Roland, Kelleners-Smeets, Nicole W.J., Lallas, Aimilios, Leiter, Ulrike, Malvehy, Josep, del Marmol, Véronique, Moreno-Ramirez, David, Pellacani, Giovanni, Peris, Ketty, Saiag, Phillippe, Tagliaferri, Luca, Trakatelli, Myrto Georgia, Ioannides, Demetrios, Vieira, Ricardo José David Costa, Zalaudek, Iris, Arenberger, Petr, Eggermont, Alexander M.M., Röcken, Martin, Grob, Jean Jacques, Lorigan, Paul C.
المساهمون: Sénopole Hopital Saint Louis, Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunology and New Concepts in ImmunoTherapy (INCIT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Assistance Publique - Hôpitaux de Marseille (APHM), The development of the current set of guidelines wassupported solely by funds of the EADO which were usedto mainly support the consensus meeting without honoraria and without reimbursement of travel costs.
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-04229549Test ; European Journal of Cancer, 2023, 193, ⟨10.1016/j.ejca.2023.113251⟩.
مصطلحات موضوعية: Advanced, Diagnosis, High-risk, Immunosuppression, Invasive cutaneous squamous cell carcinoma, Locally advanced cSCC, Metastatic cSCC, Prevention, Prognosis, Staging, [SDV.CAN]Life Sciences [q-bio]/Cancer
العلاقة: hal-04229549; https://hal.science/hal-04229549Test
-
3دورية أكاديمية
المؤلفون: Stratigos, Alexander J., Garbe, Claus, Dessinioti, Clio, Lebbe, Célèste, van Akkooi, Alexander J.C., Bataille, Véronique A., Bastholt, Lars, Dreno, Brigitte, Dummer, Reinhard G., Fargnoli, Maria Concetta, Forsea, Ana Maria, Harwood, Catherine Anne, Hauschild, Axel, Hoeller, Christoph, Kandolf-Sekulovic, Lidija O., Kaufmann, Roland, Kelleners-Smeets, Nicole W.J., Lallas, Aimilios, Leiter, Ulrike, Malvehy, Josep, del Marmol, Véronique, Moreno-Ramirez, David, Pellacani, Giovanni, Peris, Ketty, Saiag, Phillippe, Tagliaferri, Luca, Trakatelli, Myrto Georgia, Ioannides, Demetrios, Vieira, Ricardo José David Costa, Zalaudek, Iris, Arenberger, Petr, Eggermont, Alexander M.M., Röcken, Martin, Grob, Jean Jacques, Lorigan, Paul C.
المساهمون: Sénopole Hopital Saint Louis, Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunology and New Concepts in ImmunoTherapy (INCIT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Assistance Publique - Hôpitaux de Marseille (APHM), The development of the current set of guidelines wassupported solely by funds of the EADO which were usedto mainly support the consensus meeting without honoraria and without reimbursement of travel costs.
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-04229549Test ; European Journal of Cancer, 2023, 193, ⟨10.1016/j.ejca.2023.113251⟩.
مصطلحات موضوعية: Advanced, Diagnosis, High-risk, Immunosuppression, Invasive cutaneous squamous cell carcinoma, Locally advanced cSCC, Metastatic cSCC, Prevention, Prognosis, Staging, [SDV.CAN]Life Sciences [q-bio]/Cancer
العلاقة: hal-04229549; https://hal.science/hal-04229549Test
-
4دورية أكاديمية
المؤلفون: Stratigos, Alexander J., Garbe, Claus, Dessinioti, Clio, Lebbe, Célèste, van Akkooi, Alexander J.C., Bataille, Véronique A., Bastholt, Lars, Dreno, Brigitte, Dummer, Reinhard G., Fargnoli, Maria Concetta, Forsea, Ana Maria, Harwood, Catherine Anne, Hauschild, Axel, Hoeller, Christoph, Kandolf-Sekulovic, Lidija O., Kaufmann, Roland, Kelleners-Smeets, Nicole W.J., Lallas, Aimilios, Leiter, Ulrike, Malvehy, Josep, del Marmol, Véronique, Moreno-Ramirez, David, Pellacani, Giovanni, Peris, Ketty, Saiag, Phillippe, Tagliaferri, Luca, Trakatelli, Myrto Georgia, Ioannides, Demetrios, Vieira, Ricardo José David Costa, Zalaudek, Iris, Arenberger, Petr, Eggermont, Alexander M.M., Röcken, Martin, Grob, Jean Jacques, Lorigan, Paul C.
المساهمون: Sénopole Hopital Saint Louis, Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunology and New Concepts in ImmunoTherapy (INCIT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Assistance Publique - Hôpitaux de Marseille (APHM), The development of the current set of guidelines wassupported solely by funds of the EADO which were usedto mainly support the consensus meeting without honoraria and without reimbursement of travel costs.
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-04229549Test ; European Journal of Cancer, 2023, 193, ⟨10.1016/j.ejca.2023.113251⟩.
مصطلحات موضوعية: Advanced, Diagnosis, High-risk, Immunosuppression, Invasive cutaneous squamous cell carcinoma, Locally advanced cSCC, Metastatic cSCC, Prevention, Prognosis, Staging, [SDV.CAN]Life Sciences [q-bio]/Cancer
العلاقة: hal-04229549; https://hal.science/hal-04229549Test
-
5دورية أكاديمية
المؤلفون: Stratigos, Alexander J., Garbe, Claus, Dessinioti, Clio, Lebbe, Célèste, van Akkooi, Alexander J.C., Bataille, Véronique A., Bastholt, Lars, Dreno, Brigitte, Dummer, Reinhard G., Fargnoli, Maria Concetta, Forsea, Ana Maria, Harwood, Catherine Anne, Hauschild, Axel, Hoeller, Christoph, Kandolf-Sekulovic, Lidija O., Kaufmann, Roland, Kelleners-Smeets, Nicole W.J., Lallas, Aimilios, Leiter, Ulrike, Malvehy, Josep, del Marmol, Véronique, Moreno-Ramirez, David, Pellacani, Giovanni, Peris, Ketty, Saiag, Phillippe, Tagliaferri, Luca, Trakatelli, Myrto Georgia, Ioannides, Demetrios, Vieira, Ricardo José David Costa, Zalaudek, Iris, Arenberger, Petr, Eggermont, Alexander M.M., Röcken, Martin, Grob, Jean Jacques, Lorigan, Paul C.
المساهمون: Sénopole Hopital Saint Louis, Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunology and New Concepts in ImmunoTherapy (INCIT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Assistance Publique - Hôpitaux de Marseille (APHM), The development of the current set of guidelines wassupported solely by funds of the EADO which were usedto mainly support the consensus meeting without honoraria and without reimbursement of travel costs.
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-04229549Test ; European Journal of Cancer, 2023, 193, ⟨10.1016/j.ejca.2023.113251⟩.
مصطلحات موضوعية: Advanced, Diagnosis, High-risk, Immunosuppression, Invasive cutaneous squamous cell carcinoma, Locally advanced cSCC, Metastatic cSCC, Prevention, Prognosis, Staging, [SDV.CAN]Life Sciences [q-bio]/Cancer
العلاقة: hal-04229549; https://hal.science/hal-04229549Test